Pharmicell Co., Ltd.
🇰🇷South Korea
A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia
Phase 1
Withdrawn
- Conditions
- Critical Limb Ischemia
- Interventions
- Drug: Cellgram-CLI
- First Posted Date
- 2015-06-22
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- Pharmicell Co., Ltd.
- Registration Number
- NCT02477540
Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2019-01-09
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT02344849
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)
Phase 2
Completed
- Conditions
- Alcoholic Liver Cirrhosis
- Interventions
- Biological: Livercellgram
- First Posted Date
- 2013-06-11
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT01875081
- Locations
- 🇰🇷
Pharmicell Co., Ltd., Seoul, Korea, Republic of
Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury
Phase 2
Terminated
- Conditions
- Spinal Cord Injury
- Interventions
- Drug: cellgram-spine
- First Posted Date
- 2012-08-31
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01676441
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.
Phase 3
Active, not recruiting
- Conditions
- Acute Myocardial Infarction
- Interventions
- Biological: Hearticellgram-AMI
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 90
- Registration Number
- NCT01652209
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
🇰🇷Gachon University Gil Medical Center, Incheon, Korea, Republic of
🇰🇷Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction
Completed
- Conditions
- Acute Myocardial Infarction
- First Posted Date
- 2012-05-09
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 41
- Registration Number
- NCT01595113
© Copyright 2025. All Rights Reserved by MedPath